SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009466
Filing Date
2024-06-25
Accepted
2024-06-25 16:09:12
Documents
16
Period of Report
2024-06-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fbio-20240619x8k.htm   iXBRL 8-K 38729
2 EX-3.1 fbio-20240619xex3d1.htm EX-3.1 104573
3 EX-3.2 fbio-20240619xex3d2.htm EX-3.2 79941
  Complete submission text file 0001558370-24-009466.txt   422928

Data Files

Seq Description Document Type Size
4 EX-101.SCH fbio-20240619.xsd EX-101.SCH 4461
5 EX-101.DEF fbio-20240619_def.xml EX-101.DEF 15287
6 EX-101.LAB fbio-20240619_lab.xml EX-101.LAB 17712
7 EX-101.PRE fbio-20240619_pre.xml EX-101.PRE 15364
19 EXTRACTED XBRL INSTANCE DOCUMENT fbio-20240619x8k_htm.xml XML 7406
Mailing Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154
Business Address 1111 KANE CONCOURSE SUITE 301 BAY HARBOR ISLANDS FL 33154 781-652-4500
Fortress Biotech, Inc. (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35366 | Film No.: 241069019
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)